New Weight-Loss Drug Enters South African Market
A new weight-loss drug, Mounjaro, has been approved for marketing in South Africa by the South African Health Products Regulatory Authority (SAHPRA).
The medication, also known as tirzepatide, will be available as a once-weekly injection, starting in October, and will be marketed as an adjunct to a reduced-calorie diet and increased physical activity.
According to BusinessTech, this development represents a significant expansion of treatment options for weight management in South Africa, where obesity affects a growing portion of the population.
Aspen describes Mounjaro as a new tool for addressing what has become a global health challenge.
The approval positions Aspen, a South African pharmaceutical company, to compete in the rapidly expanding global market for weight-loss medications.
Author's summary: Mounjaro approved in South Africa.